Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
227.81
USD
+0.08 (+0.04%)
Official Closing Price
Updated: 7:43 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SANA
BCLI
APLS
From
Benzinga
10 Biggest Price Target Changes For Friday
March 05, 2021
SVB Leerink raised Amgen Inc. (NASDAQ: AMGN) price target from $252 to $260. Amgen shares fell 0.9% to close at $221.91 on ...
Tags
AMGN
Benzinga
PRPL
From
Benzinga
Amgen Becomes Oversold (AMGN)
March 04, 2021
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
March 04, 2021
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime Therapeutics, Inc. ("Five Prime" or the "Company") (NASDAQ: FPRX)...
From
PR Newswire
Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
March 04, 2021
The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment.
Tags
FPRX
Market News
AMGN
From
Motley Fool
Stocks Mixed Ahead of Powell's Bond Yields Update
March 04, 2021
Better-than-expected jobs data is giving sentiment a lift.
Tags
Market News
Stocks / Equities
From
Blogs - TalkMarkets
FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
March 04, 2021
From
GlobeNewswire News Releases
Why Five Prime Therapeutics Stock Is Skyrocketing Today
March 04, 2021
Amgen is paying a premium to buy the small biotech.
Tags
AMGN
Market News
FPRX
From
Motley Fool
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher
March 04, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday...
Tags
FPRX
Today's Market
NASDAQ:FPRX,NASDAQ:AMGN
From
InvestorPlace
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
March 04, 2021
Amgen Inc(NASDAQ:AMGN)has agreed to acquireFive Prime Therapeutics Inc(NASDAQ:FPRX) for $38 per ...
Tags
News
Biotech
Health Care
From
Benzinga
Five Prime Therapeutics Stock Rockets On Amgen's $1.9 Billion Takeover
March 04, 2021
Amgen said Thursday it will spend $1.9 billion to buy Five Prime Therapeutics, a small biotech company with a promising stomach cancer drug. The news sent FPRX stock rocketing.
From
Investor's Business Daily
Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash
March 04, 2021
AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH
From
Business Wire News Releases
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
March 04, 2021
Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-In-Class Program For Gastric Cancer, the Third Leading Cause of Cancer Mortality Worldwide
From
PR Newswire
Amgen Announces 2021 Second Quarter Dividend
March 03, 2021
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the second quarter of 2021. The dividend will be paid on June 8, 2021, to all stockholders of...
From
PR Newswire
Is It Time to Buy the Dow Jones' 3 Worst-Performing February Stocks?
March 03, 2021
Shares of Apple, Walmart, and Amgen didn't stumble for the reason most stocks usually sell off.
Tags
WMT
BRK/B
AMGN
From
Motley Fool
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
March 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
M&A
ITOS
Market News
From
Benzinga
BLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
March 02, 2021
Phase 3 Results Published in The Journal of The American Medical Association
From
PR Newswire
DIA, GS, AMGN, BA: Large Outflows Detected at ETF
March 02, 2021
Symbols mentioned in this story: DIA, GS, AMGN, BA Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Where Will Pfizer Be in 1 Year?
March 02, 2021
The company will face competition on many fronts before 2022 arrives.
Tags
PFE
MRNA
AMGN
From
Motley Fool
Is Now the Time to Invest in the Dow Jones?
February 28, 2021
Check your investment goals and risk tolerance to find the answer.
Tags
XOM
HON
Market News
From
Motley Fool
AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows
February 26, 2021
AstraZeneca Plc(NASDAQ:AZN) and its partnerAmgen Inc(NASDAQ:AMGN) haveannounced positive ...
Tags
AMGN
Benzinga
General
From
Benzinga
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
February 26, 2021
Data From Investigational Therapy Tezepelumab Phase 3 NAVIGATOR Trial in Patients With Severe Asthma Presented at the American Academy of Asthma Allergy & Immunology Annual Meeting
From
PR Newswire
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MRK
ORGO
DRNA
From
Benzinga
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
February 25, 2021
Moderna reports fourth quarter and fiscal year 2020 financial results and provides business updates.
From
Business Wire News Releases
Amgen To Present At The Cowen 41st Annual Healthcare Conference
February 24, 2021
Amgen (NASDAQ:AMGN) will present at the Cowen 41st Annual Virtual Healthcare Conference at 12:50 p.m. ET on Thursday, March 4, 2021. Murdo Gordon, executive vice president of Global Commercial...
From
PR Newswire
Why Turning Point Is Turning Heads
February 23, 2021
This oncology biotech is up over 450% since its April 2019 IPO. Are there still gains to come, or should investors turn away?
Tags
TPTX
AMGN
PFE
From
Motley Fool
2 Best Pharma Stocks to Buy Right Now
February 23, 2021
These under-appreciated pharma stocks have the potential to become long-term winners.
Tags
Market News
MYL
ABBV
From
Motley Fool
Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting
February 22, 2021
Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting on Friday, Feb. 26, at...
From
PR Newswire
How Does Amgen's Debt Look?
February 22, 2021
Over the past three months, shares of Amgen (NASDAQ:AMGN) rose by 2.58%. Before we understand the importance of debt, let us ...
Tags
BZI/Debt
News
Markets
From
Benzinga
Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis
February 22, 2021
Filing Based on Data From Phase 3 ADVANCE Study
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.